Post-renal transplant urolithiasis in children: an increasingly diagnosed complication: a retrospective cohort study

2019 ◽  
Vol 105 (1) ◽  
pp. 69-73
Author(s):  
Sophia Ma ◽  
Amir Taher ◽  
Benjamin Zhu ◽  
Anne Maria Durkan

ObjectiveUrolithiasis in renal transplant (RTx) recipients is a potential cause of allograft loss if obstruction is untreated. It is not clear if paediatric transplant recipients are following the global trend for increased prevalence of urolithiasis over time.Design/Setting/PatientsA retrospective chart review was undertaken to evaluate the frequency, risk factors and characteristics of post-RTx urolithiasis over two decades (1995–2016), in a tertiary Australian paediatric hospital.ResultsStones were diagnosed in 8 of 142 (5.6%) recipients, 6 of whom were transplanted in the latter decade. All patients were male, with a median age 4.9 years and median weight 11.8 kg. Presentation was with haematuria (n=4), pain (n=2), dysuria (n=2), stone passage (n=1) and asymptomatic (n=1). Time to presentation was bimodal; three stones were identified in the initial 3 months post RTx and the remainder after 31–53 months. Two stones were in association with retained suture material and two patients had recurrent urinary tract infections. The average stone size was 8.4 mm. Five stones were analysed; all contained calcium oxalate, three were mixed, including one with uric acid. Five (83.3%) children had hypercalciuria but none had hypercalcaemia. Cystolithotripsy was the the most common treatment (n=5), in combination with citrate supplementation. No graft was lost due to stones.ConclusionsCalculi occur with increasing frequency after renal transplantation. Clinicians need a high index of suspicion as symptoms may be atypical in this population. The cause for the increased frequency of stones in transplant recipients is not clear but is in keeping with the increase seen in the general paediatric population.

Author(s):  
Sameh Abdulsamea ◽  
William Bryant ◽  
Ben Margetts ◽  
John Booth ◽  
Stephen Marks

2008 ◽  
Vol 12 ◽  
pp. S10-S11
Author(s):  
Funda Timurkavnak ◽  
Süheyla Senger ◽  
Özlem Azap ◽  
Hande Arslan

2000 ◽  
Vol 69 (10) ◽  
pp. 2099-2102 ◽  
Author(s):  
Gary S. Friedman ◽  
Daniel Wik ◽  
Linda Silva ◽  
J. C. Abdou ◽  
H. U. Meier-Kriesche ◽  
...  

2011 ◽  
Vol 43 (8) ◽  
pp. 2985-2990 ◽  
Author(s):  
J. Gołębiewska ◽  
A. Dębska-Ślizień ◽  
J. Komarnicka ◽  
A. Samet ◽  
B. Rutkowski

2000 ◽  
Vol 69 (Supplement) ◽  
pp. S323
Author(s):  
Gary S. Friedman ◽  
J. C. Abdou ◽  
Linda Silva ◽  
Daniel Wik ◽  
Martin Jacobs ◽  
...  

1970 ◽  
Vol 12 (2) ◽  
pp. 103-108
Author(s):  
MD Nazrul Islam ◽  
Pradip Kumar Dutta ◽  
Mursheda Akhter ◽  
Ratan Das Gupta ◽  
MD Sahab Uddin Joardder ◽  
...  

Background: Urinary tract infections (UTIs) represent the most common cause of bacterial infection in renal allograft recipients. The purpose of this study was to evaluate UTI in renal transplant recipients at earlier post transplant period (first 3 months) and isolation of causative organism. Materials & methods: We studied 31 patients (18 males and 13 females), aged 27 ± 8.8 years. UTIs occurring during the first three months were analyzed. During this period, all episodes of infection, transplant function, graft survival and patient survival were monitored. Results: Twenty two patients had suffered from different types of infection within first 3 months of transplantation, most of the infectious episodes occurred during hospital stay. Most of the infection occurred in urinary tract and most of the episodes of UTI were asymptomatic, presented with bacteriuria. Most of the isolated organisms were Gram negative E.Coli. Out of 51 episodes of bacterial infection, UTIs account for 49 episodes (96%) Patients’ age, sex and acute rejection episodes did not correlate with UTI. Patient who had prolonged urethral catheterization had suffered from significantly more number of UTI in comparison to short period of urethral catheterization (p=0.02).Similar incidence of UTI were observed in ureteric stented and non stented patients but non stented patients had suffered from significant number of urological complication (p<0.02) . Antibiotic sensitivity pattern revealed that, all isolates were sensitive to ciprofloxacin, ceftriaxone and ceftazidime, ranged between, 67 to 100% and highly resistant to ampicillin, cotrimoxazole and cephradine. Conclusion : Short term renal graft function was not found to be affected by UTI occurrence. UTIs are common infectious complications in renal transplant recipients and often relapse and require hospitalization. Keyword: urinary tract infections (UTIs), renal transplantation, acute rejection episodes. DOI: http://dx.doi.org/10.3329/jom.v12i2.8416 JOM 2011; 12(2): 103-108


2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S931-S932
Author(s):  
Orlando Quintero ◽  
Yoram Puius ◽  
Vagish Hemmige

Abstract Background Urinary tract infections (UTIs) are a common complication of renal transplantation. Methenamine hippurate is a non-antibiotic alternative that reduces the frequency of UTIs in selected non-transplant patients, but which is not recommended in renal insufficiency. We conducted a retrospective study to determine the efficacy of methenamine prophylaxis in our kidney transplant population, and identify subgroups for which efficacy is greatest. Methods Retrospective chart review of adult kidney transplant patients at Montefiore Medical Center who were prescribed methenamine during January 1, 2016–December 31, 2017, with extraction of clinical data in the year before and after prophylaxis. Variables included demographics, creatinine clearance and hemoglobin A1c levels at the time of prescription, incidence of UTIs as determined by standardized literature definitions, hospital admissions for infections, and antibiotic use. Results The incidence of UTIs per 1000 patient-days decreased significantly, from 9.66 (95% CI 7.53–12.40) the year before to 3.24 (95% CI 2.00–5.24) the year after (P < 0.001). The effect was significantly more pronounced in patients who were transplanted due to diabetic nephropathy, with a decreased incidence of 13.05 (95% Cl 10.00–17.02) UTIs/1000 patient-days to 2.90 (95% Cl 1.58–5.32) in diabetics (P < 0.001), vs. 5.50 (95% Cl 3.65–8.28) UTIs/1000 patient-days to 3.81 (95% Cl 1.70–8.55) in non-diabetics (P = 0.44). The number of days of antibiotics for UTIs per 1000 days also decreased significantly for all patients, from 128.58 (95% CI 94.87–174.28) the year before to 49.78 (95% CI 31.74–78.07) the year after (P = 0.001). No significant differences in efficacy were seen based on sex or renal function. Three patients with indwelling urinary catheters or who required intermittent catheterization did not appear to benefit Conclusion Methenamine prophylaxis decreases the incidence of UTIs and number of antibiotic days in adult renal transplant recipients. This effect was seen even in patients with reduced creatinine clearance. Patients with diabetes benefited the most. The small number of patients who required catheterization did not appear to benefit. Disclosures All authors: No reported disclosures.


Sign in / Sign up

Export Citation Format

Share Document